To ask the Secretary of State for Health and Social Care, whether his Department has considered exempting information on how to use adrenaline devices from restrictions only allowing medical professionals to access information about prescription medicines.
Following the approval of an adrenaline nasal spray by the Medicines and Healthcare products Regulatory Agency (MHRA) in July 2025, the Government is considering whether any amendments to Schedule 17 of the Human Medicines Regulations 2012 are appropriate...
Allergies: Medical Treatments